Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.430
-0.020 (-1.38%)
Apr 28, 2025, 9:42 AM EDT - Market open
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 40 employees as of December 31, 2024. The number of employees decreased by 49 or -55.06% compared to the previous year.
Employees
40
Change (1Y)
-49
Growth (1Y)
-55.06%
Revenue / Employee
$649,575
Profits / Employee
-$1,592,275
Market Cap
66.90M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 40 | -49 | -55.06% |
Dec 31, 2023 | 89 | 10 | 12.66% |
Dec 31, 2022 | 79 | 40 | 102.56% |
Dec 31, 2021 | 39 | 31 | 387.50% |
Dec 31, 2020 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
WHWK News
- 4 weeks ago - Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals - PRNewsWire
- 5 weeks ago - Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company - PRNewsWire